Last edition
News about "hematology "
PharmaEssentia Secures Taiwan Approval for BESREMi in Essential Thrombocythemia
PharmaEssentia has received Taiwan approval for BESREMi as the first globally approved treatment for Essential Thrombocythemia (ET), marking the first new approved therapy for the disease in nearly 30 years.
Hematology | 11/06/2026 | By News Bureau
Poseida Therapeutics Welcomes Syed Rizvi as New Chief Medical Officer
Poseida Therapeutics, Inc. has appointed Syed Rizvi, MD, as Chief Medical Officer effective April 1, 2024.
<br />
Hematology | 26/03/2024 | By Manvi | 941
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy